Structural and functional imaging by MRI

Albert TSE, Kim RJ, Judd RM (2006) Assessment of no-reflow regions using cardiac MRI. Basic Res Cardiol 101:383–390 Botnar RM, Kim WY, Bornert P, Stuber M, Spuentrup E, Manning WJ (2001) 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 46:848–854 Botnar RM, Stuber M, Lamerichs R, Smink J, Fischer SE, Harvey P, Manning WJ (2003) Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 tesla. J Cardiovasc Magn Reson 5:589–594 Cai JM, Hastukami TS, Ferguson MS, Small R, Polissar NL, Yuan C (2002) Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106:1368–1373 Clarke SE, Beletsky V, Hammond RR, Hegele RA, Rutt BK (2006) Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke 37:93–97 Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ (2001) Effects of lipid-lowering by simvastatin on human atherosclerotic lesions—a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104:249–252 Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ (2005) Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions—a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 46:106–112 Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ (2002) Lipid lowering by simvastatin induces regression of human atherosclerotic lesions—two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106:2884–2887 Corti R, Osende JI, Fallon JT, Fuster V, Mizsei G, Jneid H, Wright SD, Chaplin WF, Badimon JJ (2004) The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis—in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol 43:464–473 Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R (1998) Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 97:1802–1809 Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ (2002) Progression and regression of atherosclerotic lesions—monitoring with serial noninvasive magnetic resonance imaging. Circulation 105:993–998 Itskovich VV, Samber DD, Mani V, Aguinaldo JGS, Fallon JT, Tang CY, Fuster V, Fayad ZA (2004) Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images. Magn Reson Med 52:515–523 Jacoby C, Molojavyi A, Flogel U, Merx MW, Ding ZP, Schrader J (2006) Direct comparison of magnetic resonance imaging and conductance microcatheter in the evaluation of left ventricular function in mice. Basic Res Cardiol 101:87–95 Jahnke C, Dietrich T, Paetsch I, Koehler U, Preetz K, Schnackenburg B, Fleck E, Graf K, Nagel E (2007) Experimental evaluation of the detectability of submillimeter atherosclerotic lesions in ex vivo human iliac arteries with ultrahigh-field (7.0 T) magnetic resonance imaging. Int J Cardiovasc Imaging 23:519–527 Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ (2001) In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol 21:1556–1560 Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T, Yuan C (2003) Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107:851–856 Kerwin WS, O’Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C (2006) Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241:459–468 Kim RJ, Chen EL, Lima JAC, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318–3326 Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115:228–235 Koops A, Ittrich H, Petri S, Priest A, Stork A, Lockemann U, Adam G, Weber C (2007) Multicontrast-weighted magnetic resonance imaging of atherosclerotic plaques at 3.0 and 1.5 Tesla: ex-vivo comparison with histopathologic correlation. Eur Radiol 17:279–286 Lima JAC, Desai MY, Steen H, Warren WP, Gautam S, Lai SH (2004) Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110:2336–2341 Lygate CA, Schneider JE, Hulbert K, ten Hove M, Sebag-Montefiore LM, Cassidy PJ, Clarke K, Neubauer S (2006) Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response. Basic Res Cardiol 101:8–16 Maintz D, Ozgun M, Hoffmeier A, Fischbach R, Kim WY, Stuber M, Manning WJ, Heindel W, Botnar RM (2006) Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 27:1732–1736 Manke D, Nehrke K, Bornert P (2003) Novel prospective respiratory motion correction approach for free-breathing coronary MR angiography using a patient-adapted affine motion model. Magn Res Med 50:122–131 Martin AJ, Gotlieb AI, Henkelman RM (1995) High-resolution MR-imaging of human arteries. J Magn Reson Imaging 5:93–100 McCarthy MJ, Loftus IM, Thompson MM, Jones L, London NJM, Bell PRF, Naylor AR, Brindle NPJ (1999) Angiogenesis and the atherosclerotic carotid plaque: An association between symptomatology and plaque morphology. J Vasc Surg 30:261–268 McConnell MV, Aikawa M, Maier SE, Ganz P, Libby P, Lee RT (1999) MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 19:1956–1959 Niendorf T, Hardy CJ, Giaquinto RO, Gross P, Cline HE, Zhu YD, Kenwood G, Cohen S, Grant AK, Joshi S, Rofsky NM, Sodickson DK (2006) Toward single breath-hold whole-heart coverage coronary MRA using highly accelerated parallel imaging with a 32-channel MR system. Magn Reson Med 56:167–176 Nikolaou K, Becker CR, Muders M, Babaryka G, Scheidler J, Flohr T, Loehrs U, Reiser MF, Fayad ZA (2004) Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries. Atherosclerosis 174:243–252 Takaya N, Yuan C, Chu BC, Saam T, Underhill H, Cai JM, Tran N, Polissar NL, Isaac C, Ferguson MS, Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS (2006) Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events—a prospective assessment with MRI—initial results. Stroke 37:818–823 Toussaint JF, Southern JF, Fuster V, Kantor HL (1995) T-2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 15:1533–1542 Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang HY, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta(3)-integrin-targeted nanoparticles. Circulation 108:2270–2274 Zhao XQ, Yuan C, Hatsukami TS, Frechette EH, Kang XJ, Maravilla KR, Brown BG (2001) Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI—a case-control study. Arterioscler Thromb Vasc Biol 21:1623–1629